Patents Examined by Marianne Parta Allen
  • Patent number: 5332669
    Abstract: A prostate-derived growth factor is disclosed which has a mol. wt. of about 28 kDa, an NH.sub.2 -terminal sequence substantially identical to the NH.sub.2 -terminal sequence of the 6 kDa mature rat EGF, potent mitogenic activity against NRK cells without additional carboxy terminal processing to the mature 6 kDa EGF molecular species, cross-reacts with antisera against rat EGF and its mitogenic activity is blocked by anti-EGF receptor antisera.
    Type: Grant
    Filed: May 24, 1989
    Date of Patent: July 26, 1994
    Assignee: The Jewish Hospital of St. Louis
    Inventor: Thomas F. Deuel